DEBANANDA PATI to Antineoplastic Agents
This is a "connection" page, showing publications DEBANANDA PATI has written about Antineoplastic Agents.
Connection Strength
0.705
-
Toxicity study of separase inhibitor-Sepin-1 in Sprague-Dawley rats. Pathol Res Pract. 2020 Jan; 216(1):152730.
Score: 0.351
-
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy. J Biomol Screen. 2014 Jul; 19(6):878-89.
Score: 0.236
-
Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeterminate potential. Am J Hematol. 2019 03; 94(3):E82-E85.
Score: 0.083
-
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.
Score: 0.036